prostate carcinoma (Cancer)
Information
- Disease name
- prostate carcinoma
- Disease ID
- DOID:10286
- Description
- "A prostate cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells." [url:http\://en.wikipedia.org/wiki/Carcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04788277 | Active, not recruiting | Detection of Prostate Cancer Using Voided Urine | February 26, 2020 | June 2025 | |
| NCT02465060 | Active, not recruiting | Phase 2 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | August 17, 2015 | December 31, 2025 |
| NCT03220945 | Active, not recruiting | N/A | Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer | January 6, 2016 | January 31, 2025 |
| NCT03263650 | Active, not recruiting | Phase 2 | Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC | October 3, 2017 | June 30, 2024 |
| NCT05047965 | Active, not recruiting | N/A | An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer | April 25, 2013 | February 2, 2027 |
| NCT04905082 | Active, not recruiting | N/A | HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | December 30, 2021 | June 30, 2024 |
| NCT05011799 | Active, not recruiting | N/A | The Peer Genetic Study | January 8, 2020 | September 28, 2024 |
| NCT04600336 | Active, not recruiting | Phase 2 | Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer | October 28, 2021 | May 2024 |
| NCT05055843 | Active, not recruiting | N/A | Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer | August 10, 2021 | January 31, 2025 |
| NCT04484818 | Active, not recruiting | Phase 3 | Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study | March 1, 2021 | May 31, 2028 |
| NCT04457232 | Active, not recruiting | Phase 1 | Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation | September 9, 2020 | September 9, 2025 |
| NCT03580499 | Active, not recruiting | N/A | Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy | September 13, 2018 | December 2024 |
| NCT02722525 | Active, not recruiting | N/A | Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer | December 2014 | December 31, 2024 |
| NCT03661437 | Active, not recruiting | Early Phase 1 | Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy | September 24, 2018 | December 31, 2024 |
| NCT04299620 | Active, not recruiting | N/A | Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy | October 21, 2020 | September 1, 2025 |
| NCT03035500 | Active, not recruiting | N/A | Long-Term Follow-Up in Patients With Prostate Cancer After Surgery | July 23, 2008 | December 30, 2024 |
| NCT03085043 | Active, not recruiting | N/A | Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer | April 20, 2016 | April 30, 2026 |
| NCT00002540 | Active, not recruiting | N/A | Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) | November 16, 1993 | March 11, 2025 |
| NCT05470699 | Active, not recruiting | N/A | RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer | August 29, 2022 | April 20, 2025 |
| NCT03135782 | Completed | N/A | Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy | August 1, 2017 | September 23, 2020 |
| NCT04763980 | Completed | N/A | Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer | January 15, 2021 | March 31, 2022 |
| NCT04626466 | Completed | Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation | August 3, 2020 | January 2, 2024 | |
| NCT03326440 | Completed | N/A | Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer | October 8, 2015 | May 31, 2018 |
| NCT03406013 | Completed | N/A | Internet-Based Exercise and Diet Support in Prostate Cancer Survivors | August 1, 2017 | March 31, 2020 |
| NCT03418025 | Completed | N/A | Exercising Together During Radiation Treatment | November 1, 2017 | October 23, 2018 |
| NCT03630354 | Completed | N/A | EXERCISING TOGETHER for Couples Coping With Cancer | January 18, 2019 | January 1, 2024 |
| NCT03741335 | Completed | N/A | GET FIT Prostate: A Randomized Controlled Exercise Trial | February 5, 2019 | January 1, 2024 |
| NCT04282824 | Completed | Early Phase 1 | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer | June 5, 2019 | May 6, 2020 |
| NCT03849469 | Completed | Phase 1 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors | May 29, 2019 | February 16, 2023 |
| NCT04050215 | Completed | Phase 2 | 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer | April 2, 2018 | September 27, 2021 |
| NCT04106245 | Completed | N/A | Effect of EHealth Coaching Program on Patient Reported Outcomes of Men With Prostate Cancer | December 4, 2019 | July 27, 2023 |
| NCT00170157 | Completed | Phase 2 | Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer | June 2004 | June 2013 |
| NCT00540059 | Completed | Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial | June 2005 | ||
| NCT00892736 | Completed | Phase 1 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | April 20, 2009 | May 19, 2017 |
| NCT01497431 | Completed | Phase 1 | Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants | November 2011 | July 2014 |
| NCT02002455 | Completed | Phase 2 | Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI | December 2013 | June 2016 |
| NCT05895279 | Completed | N/A | Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study | August 2, 2021 | September 30, 2021 |
| NCT02337465 | Completed | N/A | KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer | September 22, 2015 | December 14, 2019 |
| NCT02425800 | Completed | Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells | July 28, 2015 | August 3, 2021 | |
| NCT02440308 | Completed | Phase 2 | 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer | April 2015 | June 30, 2015 |
| NCT02704377 | Completed | N/A | Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors | May 8, 2016 | April 6, 2023 |
| NCT04976257 | Completed | Early Phase 1 | Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion | October 13, 2021 | March 22, 2023 |
| NCT02869412 | Completed | N/A | Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy | January 2015 | July 31, 2017 |
| NCT02927899 | Completed | N/A | Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer | April 15, 2015 | April 15, 2015 |
| NCT02957981 | Completed | N/A | The Genetic Education for Men Trial: Web-Based Education vs. Standard Care | October 1, 2018 | April 1, 2022 |
| NCT02991794 | Completed | Prostatectomies Using Einstein Vision® 3D | May 19, 2017 | November 6, 2020 | |
| NCT04902144 | Completed | N/A | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | August 3, 2020 | December 31, 2021 |
| NCT03013413 | Completed | N/A | Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy | September 2011 | May 2014 |
| NCT03101046 | Completed | Phase 2 | Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic | November 15, 2018 | December 31, 2021 |
| NCT06347809 | Enrolling by invitation | DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine | November 7, 2018 | February 1, 2029 | |
| NCT04081779 | Enrolling by invitation | N/A | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | February 19, 2020 | December 31, 2025 |
| NCT04254133 | Enrolling by invitation | Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study | November 30, 2018 | August 31, 2028 | |
| NCT05012813 | Enrolling by invitation | N/A | Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer | July 19, 2022 | December 31, 2025 |
| NCT06094842 | Not yet recruiting | Phase 1 | Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer | July 1, 2024 | March 15, 2028 |
| NCT06024772 | Not yet recruiting | Phase 3 | Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer | June 2024 | February 2027 |
| NCT06216249 | Not yet recruiting | Phase 2 | Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | July 1, 2024 | February 1, 2028 |
| NCT04910425 | Not yet recruiting | Phase 2 | PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer | June 17, 2023 | July 2028 |
| NCT04597359 | Recruiting | Phase 2 | To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring | October 5, 2021 | December 31, 2032 |
| NCT04646434 | Recruiting | N/A | Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy | July 13, 2023 | July 13, 2029 |
| NCT06326216 | Recruiting | Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer | June 10, 2020 | July 1, 2025 | |
| NCT03697148 | Recruiting | N/A | Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer | February 11, 2019 | August 1, 2025 |
| NCT04472338 | Recruiting | Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study | May 21, 2020 | August 31, 2030 | |
| NCT03485794 | Recruiting | Collection of Blood in Studying Metabolites in Patients With Prostate Cancer | November 14, 2017 | November 14, 2026 | |
| NCT05438563 | Recruiting | N/A | MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer | April 6, 2022 | March 7, 2026 |
| NCT05519878 | Recruiting | N/A | Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers | November 29, 2022 | May 25, 2027 |
| NCT05764330 | Recruiting | N/A | Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance | April 24, 2024 | April 30, 2025 |
| NCT05766371 | Recruiting | Phase 2 | Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer | December 15, 2023 | May 31, 2031 |
| NCT05819827 | Recruiting | Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics | April 19, 2023 | March 27, 2025 | |
| NCT05869682 | Recruiting | Phase 2 | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy | June 15, 2024 | December 1, 2027 |
| NCT06011499 | Recruiting | N/A | Internet-Based Lifestyle Intervention (iLIVE) to Eradicate Obese Frailty in Prostate Cancer Survivors | April 2, 2024 | December 31, 2027 |
| NCT06016504 | Recruiting | N/A | Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients With Prostate Cancer | February 10, 2022 | December 31, 2035 |
| NCT06037863 | Recruiting | N/A | Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial | September 19, 2023 | September 19, 2028 |
| NCT06049355 | Recruiting | Phase 2 | EMBRACE: Exercising Together | April 18, 2024 | September 1, 2028 |
| NCT06067295 | Recruiting | Longitudinal Advanced Prostate Cancer Cohort (LAPCC) | February 21, 2023 | February 21, 2027 | |
| NCT06128525 | Recruiting | N/A | Prostate Resection After Microwave Ablation (PRAMA) | November 10, 2023 | November 10, 2025 |
| NCT06200259 | Recruiting | N/A | Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement | January 8, 2024 | January 2, 2040 |
| NCT04030559 | Recruiting | Phase 2 | Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects | February 25, 2020 | February 1, 2025 |
| NCT03772834 | Recruiting | Phase 2/Phase 3 | Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer | March 25, 2019 | November 30, 2026 |
| NCT04765150 | Recruiting | Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification | April 1, 2021 | June 1, 2027 | |
| NCT04789018 | Recruiting | Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study | January 21, 2020 | June 24, 2025 | |
| NCT04857502 | Recruiting | Early Phase 1 | 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer | April 27, 2021 | June 1, 2025 |
| NCT04879940 | Recruiting | Phase 2 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | February 23, 2022 | August 1, 2024 |
| NCT02994758 | Recruiting | N/A | Development of Diagnostics and Treatment of Urological Cancers | November 27, 2017 | December 2025 |
| NCT02960087 | Recruiting | N/A | Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer | March 6, 2017 | March 31, 2029 |
| NCT04947254 | Recruiting | Phase 2 | Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer | August 5, 2021 | June 7, 2026 |
| NCT02739659 | Recruiting | N/A | Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer | January 2016 | December 31, 2024 |
| NCT05067777 | Recruiting | Phase 2 | Massage for Prostate Cancer-Related Fatigue, mPROSTATE Study | April 25, 2022 | October 30, 2027 |
| NCT05160597 | Recruiting | Early Phase 1 | Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy | January 13, 2022 | January 7, 2026 |
| NCT05167175 | Recruiting | Phase 2 | The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | March 1, 2022 | December 1, 2024 |
| NCT05336786 | Recruiting | Phase 3 | Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) | June 15, 2022 | August 31, 2024 |
| NCT04955808 | Suspended | Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | February 7, 2017 | December 31, 2026 | |
| NCT05362032 | Suspended | N/A | Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate | May 8, 2023 | May 26, 2025 |
| NCT03284346 | Terminated | N/A | Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors | August 17, 2017 | July 15, 2019 |
| NCT02140138 | Terminated | Phase 2 | An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer | June 2014 | April 2016 |
| NCT02421575 | Terminated | Early Phase 1 | Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | July 2012 | February 26, 2016 |
| NCT03152786 | Terminated | Phase 2 | Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery | January 15, 2019 | February 28, 2023 |
| NCT02501759 | Terminated | N/A | Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer | May 2015 | February 10, 2017 |
| NCT02419846 | Terminated | N/A | Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program | June 1, 2015 | July 2022 |
| NCT03196388 | Unknown status | Phase 2 | Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer | December 27, 2017 | December 2018 |
| NCT05262608 | Unknown status | Phase 2 | The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation | December 7, 2021 | April 26, 2024 |
| NCT04699344 | Unknown status | A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis | January 25, 2021 | June 30, 2023 | |
| NCT02484339 | Unknown status | Phase 2 | Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT) | December 2014 | December 2017 |
| NCT03563352 | Withdrawn | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer | August 30, 2018 | September 24, 2020 | |
| NCT01561482 | Withdrawn | Phase 2 | Study of Metformin With Simvastatin for Men With Prostate Carcinoma | January 2012 | July 2014 |
| NCT03408561 | Withdrawn | N/A | Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | November 8, 2017 | December 31, 2018 |
- Disase is a (Disease Ontology)
- DOID:10283
- Cross Reference ID (Disease Ontology)
- EFO:0001663
- Cross Reference ID (Disease Ontology)
- KEGG:05215
- Cross Reference ID (Disease Ontology)
- NCI:C4863
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:254900004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0600139
- Exact Synonym (Disease Ontology)
- cancer of prostate
- Exact Synonym (Disease Ontology)
- carcinoma of prostate